Minot Wealth Management LLC Bristol Myers Squibb CO Transaction History

Minot Wealth Management LLC

$389 Million
Q2 2022

A detailed history of Minot Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Minot Wealth Management LLC holds 56,800 shares of BMY stock, worth $2.25 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

56,800

Previous 25,925 119.09%

Holding current value

$2.25 Million

Previous $1.89 Million 131.06%

% of portfolio

1.12%

Previous 0.41%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $2.24 Million - $2.47 Million	30,875 Added 119.09%	56,800 $4.37 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $1.04 Million - $1.24 Million	16,853 Added 185.77%	25,925 $1.89 Million
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $731,781 - $853,085	-13,645 Reduced 60.07%	9,072 $566,000
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $17,691 - $20,723	299 Added 1.33%	22,717 $1.34 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $124,562 - $135,649	2,012 Added 9.86%	22,418 $1.51 Million

Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $1.31 Million - $1.47 Million	-22,008 Reduced 51.89%	20,406 $1.29 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $318,436 - $360,846	-5,515 Reduced 11.51%	42,414 $2.63 Million
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $367,149 - $406,850	6,393 Added 15.39%	47,929 $2.89 Million
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $1.9 Million - $2.22 Million	34,620 Added 500.58%	41,536 $2.44 Million
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $130,291 - $189,343	2,808 Added 68.35%	6,916 $385,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $202,154 - $263,692	4,108 New	4,108 $277,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Minot Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Minot Wealth Management LLC with notifications on news.

Account

Minot Wealth Management LLC Bristol Myers Squibb CO Transaction History